Screener
Phathom Pharmaceuticals, Inc. PHAT Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324867
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Restricted cash | 2,864 | 2,861 |
| Inventory, non-current | 21,827 | 20,732 |
| Other long-term assets | 3,088 | 2,917 |
| Total assets | $327,075 | $259,149 |
| Liabilities and Stockholders’ Deficit | ||
| Current liabilities: | ||
| Accounts payable | $5,361 | $4,983 |
| Accrued expenses | 109,027 | 89,831 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Phathom Pharmaceuticals, Inc.'s total assets?
- Phathom Pharmaceuticals, Inc. (PHAT) reported total assets of $327.08M in Q2 2026.
- How has Phathom Pharmaceuticals, Inc.'s total assets changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s total assets increased by 30.7% year-over-year, from $250.22M to $327.08M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s total assets?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s total assets has grown at a -2.6% compound annual growth rate (CAGR), from $295.11M to $259.15M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Phathom Pharmaceuticals, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude